Switching antipsychotic treatment to aripiprazole in psychotic patients with neuroleptic-induced tardive dyskinesia: A 24-week follow-up study
International Clinical Psychopharmacology Jan 18, 2018
Chia-Hsiang C, et al. - The effectiveness of aripiprazole was examined in psychotic patients with a pre-existing tardive dyskinesia (TD). Researchers revealed that in psychotic patients with TD, aripiprazole could be a promising treatment for clinicians considering drug switch.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
